세계의 골 통증 치료 시장 보고서(2025년)
Bone Pain Treatment Global Market Report 2025
상품코드 : 1764266
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

골 통증 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.3%로 성장할 전망이며, 80억 1,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 골 통증의 표적 생물학적 요법에 대한 수요 증가, 비침습적 치료 옵션에 대한 기호 증가, 골 통증 관리에서 개별화 의료의 채용 확대, 시판 진통제의 수요 확대, 신흥 시장에서 헬스케어에의 액세스 개선 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 골 통증 관리에서의 인공지능 통합, 통증 완화를 위한 가상현실 이용, 골다공증성 골 통증 치료에서의 진보, 기술 강화형 통증 완화 장치 개발, 크로스테라피 통합, 외과적 개입에서의 로봇공학 도입 등이 있습니다.

골다공증의 유병률 증가는 향후 골 통증 치료 시장의 성장을 가속할 것으로 예측됩니다. 골다공증은 골밀도나 강도가 저하되어 뼈가 약해지고 쉽게 골절되는 질환입니다. 골밀도는 일반적으로 나이가 들면서 저하되기 때문에, 이 질환은 주로 세계 인구의 고령화에 의해 일반적으로 되고 있습니다. 골 통증 치료는 골다공증에 따른 불쾌감을 완화하고 운동 능력을 향상시키며 삶의 질 향상을 지원함으로써 골다공증의 통증 관리에 중요한 역할을 하고 있습니다. 예를 들어 2024년 6월 호주 보건복지랩은 2022년에는 호주에서 약 85만 3,600명이 골다공증 또는 골감소증에 이환됐으며 같은 해 사망자 수는 2,659명이었다고 보고했습니다. 따라서 골다공증의 유병률 상승은 효과적인 골통 치료에 대한 수요를 크게 촉진하고 있습니다.

골 통증 치료 시장에서 사업을 전개하는 주요 기업은 처방전이 있는 웨어러블 기기 등 표적을 좁힌 통증 완화를 실현하는 혁신적인 솔루션의 개발에 주력하고 있습니다. 이러한 의료 승인 장치는 신체에 장착하고 전기 자극 및 진동과 같은 치료법을 제공하여 혈액 순환을 촉진하고 염증을 억제하며 통증 신호를 차단하여 골 통증을 완화합니다. 예를 들어, 2025년 5월 미국 의료기기 제조업체인 오스테오 부스트 헬스는 골밀도가 낮은 사람들을 위해 특별히 설계된 최초의 FDA 승인 웨어러블 장비인 오스테오 부스트를 출시했습니다. 이 웨어러블 벨트는 저진폭의 고주파 진동 요법(20-40Hz)을 척추와 엉덩이에 주고, 골감소증 폐경 후 여성의 골밀도와 강도 저하를 늦추는 것을 목적으로 합니다. 정상적인 활동 중에 매일 30분 동안 사용할 수 있도록 설계되었으며, Osteoboost는 심각한 부작용 없이 골 건강을 유지하는 임상적 효과를 입증합니다. 오스테오 부스트는 전동 진동 팩, 압력 센서, 가속도계를 내장하고 정확하고 안전한 치료를 할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Bone pain treatment involves medical interventions aimed at relieving discomfort or aching in the bones, which may result from conditions such as fractures, infections, cancer, or chronic illnesses. These treatments typically encompass medications, physical therapy, and, in some cases, surgical procedures to target the root cause and mitigate pain.

The primary categories of bone pain treatment include pharmacological treatments, non-pharmacological approaches, and surgical interventions. Pharmacological treatments involve the use of drugs to prevent, manage, or treat medical conditions by influencing specific biological functions. The drug classes commonly employed include analgesics, antidepressants, anticonvulsants, and corticosteroids. Bone pain is generally treated for conditions such as injuries, infections, myalgia, and tumors. Treatment options are distributed via direct sales, retail pharmacies, and online pharmacies, and are used by end users such as hospitals, clinics, and homecare settings.

The bone pain treatment market research report is one of a series of new reports from The Business Research Company that provides bone pain treatment market statistics, including the bone pain treatment industry's global market size, regional shares, competitors with the bone pain treatment market share, detailed bone pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bone pain treatment market. This bone pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone pain treatment market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of chronic conditions such as osteoporosis and arthritis, a surge in bone disorder cases, an expanding elderly population, increasing awareness regarding bone health, and a higher incidence of cancer-related bone metastases.

The bone pain treatment market size is expected to see strong growth in the next few years. It will grow to $8.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for targeted biologic therapies for bone pain, rising preference for non-invasive treatment options, the expanding adoption of personalized medicine in bone pain management, growing demand for over-the-counter pain relievers, and improved access to healthcare in emerging markets. Key trends anticipated during this period include the integration of artificial intelligence in bone pain management, the use of virtual reality for pain relief, advancements in treatments for osteoporotic bone pain, the development of technology-enhanced pain relief devices, cross-therapy integration, and the incorporation of robotics in surgical interventions.

The increasing prevalence of osteoporosis is expected to propel the growth of the bone pain treatment market going forward. Osteoporosis is a condition marked by reduced bone density and strength, making bones more fragile and susceptible to fractures. This condition is becoming more common, primarily due to the aging global population, as bone density typically decreases with age. Bone pain treatments play a critical role in managing osteoporosis by relieving associated discomfort, improving mobility, and supporting better quality of life. For instance, in June 2024, the Australian Institute of Health and Welfare reported that approximately 853,600 individuals in Australia were living with osteoporosis or osteopenia in 2022, with the disease contributing to 2,659 deaths that year. Therefore, the rising prevalence of osteoporosis is significantly driving the demand for effective bone pain treatments.

Major companies operating in the bone pain treatment market are focusing on developing innovative solutions, such as prescription wearable devices, to deliver targeted pain relief. These medically approved devices are worn on the body and offer therapies like electrical stimulation or vibration to alleviate bone pain by enhancing circulation, reducing inflammation, or disrupting pain signals. For instance, in May 2025, Osteoboost Health Inc., a US-based medical equipment manufacturer, launched Osteoboost, the first FDA-cleared wearable device specifically designed for individuals with low bone density. This wearable belt delivers low-amplitude, high-frequency vibration therapy (20-40 Hz) to the spine and hips and is intended to slow the loss of bone density and strength in postmenopausal women with osteopenia. Designed for daily 30-minute use during normal activities, Osteoboost has demonstrated clinical efficacy in preserving bone health without significant adverse events. The device integrates a motorized vibration pack, pressure sensor, and accelerometers to ensure precise and safe therapy delivery.

In November 2023, Boston Scientific Corporation, a US-based biotechnology company, acquired Relievant Medsystems Inc. for $850 million. This strategic acquisition was aimed at expanding Boston Scientific's chronic pain management portfolio and reinforcing its leadership in the interventional pain space. By integrating Relievant's innovative, FDA-cleared solutions, the company seeks to enhance patient access to effective treatments and improve clinical outcomes. Relievant Medsystems Inc., also based in the US, specializes in treating chronic low back pain, with a particular focus on vertebrogenic pain, offering targeted therapies that address the underlying source of pain.

Major players in the bone pain treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Novartis International AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc., Stryker Corporation, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Endo International plc, Amneal Pharmaceuticals Inc., Marksans Pharma Limited, and APS Materials Inc.

North America was the largest region in the bone pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bone pain treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bone pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bone pain treatment market includes revenues earned by entities by providing services such as pharmacological therapy services, physical therapy and rehabilitation services, surgical intervention services, pain management clinics, and diagnostic imaging and evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bone pain treatment also includes sales of acetaminophen, ibuprofen, naproxen, morphine, oxycodone, alendronate, and prednisone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bone pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bone Pain Treatment Market Characteristics

3. Bone Pain Treatment Market Trends And Strategies

4. Bone Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bone Pain Treatment Growth Analysis And Strategic Analysis Framework

6. Bone Pain Treatment Market Segmentation

7. Bone Pain Treatment Market Regional And Country Analysis

8. Asia-Pacific Bone Pain Treatment Market

9. China Bone Pain Treatment Market

10. India Bone Pain Treatment Market

11. Japan Bone Pain Treatment Market

12. Australia Bone Pain Treatment Market

13. Indonesia Bone Pain Treatment Market

14. South Korea Bone Pain Treatment Market

15. Western Europe Bone Pain Treatment Market

16. UK Bone Pain Treatment Market

17. Germany Bone Pain Treatment Market

18. France Bone Pain Treatment Market

19. Italy Bone Pain Treatment Market

20. Spain Bone Pain Treatment Market

21. Eastern Europe Bone Pain Treatment Market

22. Russia Bone Pain Treatment Market

23. North America Bone Pain Treatment Market

24. USA Bone Pain Treatment Market

25. Canada Bone Pain Treatment Market

26. South America Bone Pain Treatment Market

27. Brazil Bone Pain Treatment Market

28. Middle East Bone Pain Treatment Market

29. Africa Bone Pain Treatment Market

30. Bone Pain Treatment Market Competitive Landscape And Company Profiles

31. Bone Pain Treatment Market Other Major And Innovative Companies

32. Global Bone Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bone Pain Treatment Market

34. Recent Developments In The Bone Pain Treatment Market

35. Bone Pain Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기